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Evidence has been presented which shows that,  following experi- 
mental infection with the virus of human influenza, animals develop a 
state of resistance to reinfection, and the sera of such recovered ani- 
mals manifest a specific power to protect mice against infection with 
the homologous  virus (1-3).  Furthermore, the sera of human individ. 
uals  develop protective  properties  against  human  strains  of  virus 
following  recovery  from  naturally  acquired  influenza  (3).  The 
antibodies which develop have been found to persist for 6 to 8 months 
at least. 
Since the presence of antibodies against the human influenza virus 
in the serum appears to be an expression of a previous infection with 
the virus, it is important to determine the frequency with which these 
antibodies occur in the serum of human individuals in the population 
at large.  To this end, serum was obtained from 136 human beings in 
New York, Philadelphia, Princeton, and Baltimore, and the sera were 
tested for their capacity to protect mice against a  strain of human 
influenza virus  (P.  R.  8).  So  far  as  possible,  histories  concerning 
previous attacks of influenza were also obtained from the same in= 
dividuals. 
The present report deals with the results of mouse protection tests 
made with these sera against a strain of human influenza virus (P. R. 
8).  The individuals from whom the sera were obtained ranged from 
newborn infants to adults in the eighth decade of life. 
Methods and Materials 
Sera.--The  samples of serum  used  in  these  tests were  derived from  clotted 
venous blood.  The majority of the children's sera were obtained from children 
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in the wards of the Hospital for the Ruptured and  Crippled, New York  City.  1 
In practically all instances the children were hospitalized because of orthopedic 
disabilities. 
Most  of  the  specimens of  serum  of elderly individuals were  obtained from 
healthy persons at the Baltimore City Hospital, Baltimore. 
Serum was obtained from  18  individuals of various ages in Philadelphia.  ~ 
A few specimens were obtained by Dr. Shope at Princeton. 
The majority of the other samples were obtained from staff members or attend- 
ants at The Rockefeller Institute. 
Virus.--The strain of virus employed in  these tests was recovered from an 
epidemic of influenza in Puerto Rico (4), and has been maintained in white mice 
through serial passages by the inoculation of suspensions of infected mouse lungs 
into the nasal passages of normal mice. 
Mouse Protection Tests.--The capacity of serum  to protect white mice from 
the action of the virus was tested in the following manner. 
Mice infected with virus were killed when moribund, and their lungs removed 
with  aseptic precautions.  Weighed amounts  of the  infected mouse lung  were 
ground with alundum and suspended in physiological salt solution to form a  10 
per cent suspension.  The suspension was centrifugalized for 10 to 15 minutes at 
1500  R.I'.~.  The  supernatant liquid was removed and 0.3  cc.  of the fluid was 
mixed with  0.3  cc.  of  the  serum  to  be  tested.  The  serum-virus mixture  was 
incubated at 37°C.  for 30 minutes.  Each of 4  Swiss mice was then inoculated 
intranasally, while anesthetized with ether, with 0.03  cc. of the mixture. 
The mice were observed for 6 days after inoculation.  All animals which died 
during this period were autopsied, and their lungs examined.  On the 6th day, all 
survivors were killed and their lungs were examined for gross pulmonary lesions. 
The severity of the pulmonary lesions in each mouse was graded by the amount 
of pulmonary tissue involved as viewed by the naked eye.  The various degrees 
of involvement varied from  ±, in which only small pinpoint areas of congestion 
were seen, to +  +  +  +, in which all five lobes of the mouse lung were completely 
involved.  The result of the test with a given serum was determined by making 
an approximate average of the extent of the lesions in the 4 mice inoculated with 
each serum-virus mixture.  For example, if the lesions in 4 mice were  +,  +,  +, 
+  +, respectively, the final result would be considered  +.  If the lesions were 
++,  +++,  +,  ++,  respectively, the result would be classified as  ++.  If 
+,  +, 0, 0, the result would be considered incomplete protection and graded ±; 
but for practical purposes these latter results may be considered to indicate com- 
plete protection.  Mice presenting average lesions of +  +  +  or greater were con- 
sidered not to have been protected, while in those tests in which an average of +, 
or  ++,  lesions appeared,  the  serum  was  considered to  have  afforded partial 
protection to the mice.  In the absence of pulmonary lesions, the result was ac- 
counted complete protection. 
i Through the courtesy of Dr. Stefanson. 
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With each series of tests, control tests were made, using one sample of human 
serum which did not protect mice, and another which afforded complete protec- 
tion to mice.  In all instances the results with the control sera were negative and 
positive, respectively. 
While certain variations in the extent of the pulmonary lesions obtained with 
the same serum in different tests were observed, they were usually of a  minor 
nature, and were never of sufficient degree to require a complete reclassification of 
the serum.  With the strong concentration of virus used, a 10 to 20 per cent varia- 
tion in the concentration of virus in different tests might occur without seriously 
altering the results.  Another source of variation which was impossible to control 
was the size of the mice.  So far as possible, mice 4 to 6 weeks of age were used. 
However, considerable differences in the size of animals occurred, and it has been 
recognized that large mice are more resistant to infection than small ones of 12 
to 15 gm. 
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CEART 1.  The results of mouse protection tests made with human serum classi- 
fied according to age of donor.  Human influenza virus (P.R. 8). 
RESULTS 
The results  are presented in Chart I, in which each black circle  rep- 
resents the test  made with the serum of a single  individual, and the 
results  are  distributed  according to the age of  the donor from whom  the 
serum was obtained.  The number of individuals in the different  age 
groups varies,  with a relative  preponderance of children below 5 years 
of age, and a disproportionately small number  between the ages of 658  ANTIBODIES  YOR HUMAN  INFLUENZA  VIRUS 
10 and 19.  While the entire group is small from a statistical point of 
view,  the  trend of  the  results  is  sufficiently regular  to  appear  fig- 
nificant. 
The sera  have  been  classified,  as  affording  complete  protection, 
partial protection, or no protection.  Complete protection was effected 
by 49 per cent of all sera, partial protection by 29 per cent, and 21 per 
cent were considered to be non-protective.  Distinct differences were 
noted in  the percentage of protective sera at different  ages.  These 
figures are presented in Table I and Chart 2. 
TABLE  I 
The Protective Action of Scra of Individuals of Different  Ages  against 
Human Influenza  Virus 
Age of donor 
Newborn 
1 mo.-I yr. 
1-5  yrs. 
6-9  " 
10--19  " 
20-29  " 
30-39  " 
40-49  " 
50-59  " 
60-1-  " 
Total .... 
No. of sera 
11 
8 
15 
10 
12 
17 
23 
16 
14 
i0 
136 
Sera affording 
Partial protection  No protection  Complete protection 
No.  per cent  No. 
6  54.5  5 
1  12.5  1 
10  66.6  0 
5  50.0  3 
7  58.3  3 
9  52.9  6 
12  52.1  9 
6  37.5  7 
7  50.0  3 
4  40.0  3 
67  49.2  40 
~$f Cfng 
45.5 
12.5 
0.0 
30.0 
25.0 
35.3 
i  39.! 
43.7 
21.4 
30.0 
I  29.4 
No,  per cen~ 
0  0,0 
6  75,0 
5  33,3 
2  20.0 
2  16,6 
2  11.8 
2  8.8 
3  18.8 
4  28.5 
2  20.0 
29  21.3 
The frequency of completely protective sera in  newborn infants  is 
approximately the same as in middle aged individuals.  After the 1st 
month of life, a  sharp drop in the percentage of positive sera occurs 
and persists  through the  1st year of life.  Between the  1st and 5th 
years of life, however, the percentage of positive results  reaches its 
height, and 66 per cent of the sera in this age group possess the capacity 
to protect mice completely against the  virus.  From that time until 
the 40th year of life, complete protection was nearly or quite as  fre- 
quent; thereafter the incidence of protective sera declined somewhat. 
The trend of the findings is more even if the age groups are combined 
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The results have also been classified according to whether or not the 
individuals from whom serum was obtained had experienced an attack 
of influenza (Table II).  Tests with the sera of children below the age 
of 12 years were not included because of the frequent lack of satis- 
factory histories.  In spite of the inaccuracies which occur, a definite 
o 
¢) 
D=No p~tection 
=Pm~t p~otection 
I=Com~lele protection 
CHART 2. The percentage of human sera exerting protective action against 
human influenza  virus (P.R. 8). 
* Indicates per cent of completely  protective sera when the two adjacent age 
groups are combined. 
statement regarding previous influenza was obtained from 78 individ- 
uals.  In  this  group  there  appears  to  be  some  relation  between  a 
history of influenza and a  strongly protective serum, since 55.5  per 
cent of the individuals who were said to have had influenza, and only 
39.3  per cent of those without histories of influenza, possessed suffi- 
cient circulating antibody to furnish complete protection to mice; 660  ANTIBODIES  FOR  HUMAN  INI?LUENZA  VIRUS 
The sera of the individuals giving positive histories of influenza may 
again be grouped according to the time at which the illness was experi- 
enced  (Table  III).  The  results  show  that  the  sera of  individuals 
alleged to have had influenza in 1918 were equally divided among the 
protective and non-protective groups,  a  result not largely different 
from the average of the entire series which was studied.  The individ- 
TABLE  II 
The Relation of Results of Serum-Virus Protection Tests to History 
of Influenza 
History of influenza  No. of sera  Protecting  Not protecting 
per cent  per cent 
Yes  45  55.5 (25)  44.5 (20) 
No  33  39.3 (13)  60.7 (20) 
Total .............  78  48.7  51.3 
Numbers in parentheses indicate the number of samples included. 
TABLE  III 
The Relation of the Time of Illness to Protective  Property of the Serum 
Time of illness  No. of sera  Protective  Non-protective 
1918-23 
1933-35 
1918 and 1930-35 
Indefinite 
1934-35 
(Convalescents, 
Puerto Rico 
and Alaska) 
18  9 
12  10 
6  3 
11  3 
19  17 
uals who did not clearly remember the time of illness were in the older 
age groups, and may be considered not to have suffered from influenza 
recently.  On the other hand the incidence of completely protective 
sera was considerably greater among the 12 individuals in this series 
who had suffered from influenza in the past few years, the majority of 
whom were observed by one of us.  In addition to  the  12  samples 
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seaboard,  it  has  been  possible  to  test  the  convalescent serum  of  4 
subjects  in  Puerto  Rico from whom  the original virus material was 
obtained, and the sera of 1S individuals convalescent from the influenza 
epidemic which occurred in Alaska in May, 1935.  8  Complete protec- 
tion resulted with 27, or 87 per cent, of these 31 sera, an incidence of 
positive  sera  not  otherwise  encountered.  These  results  indicate 
dearly that the occurrence of recent influenza in a group of individuals 
is followed by a high proportion of strongly protective sera. 
In addition to the sera which contained sufficient antibody to protect 
mice completely against the human influenza virus, 29 per cent were 
found to afford partial protection; the latter may, therefore, be con- 
sidered protective sera of lower titer than those of the former group. 
With this granted, the sera of all new-born infants are found to contain 
protective antibodies.  After the 1st year of life the incidence of anti- 
bodies increases  to its maximum between  the  20th  and  40th  years, 
when 90 per cent of the sera confer complete or partial protection on 
mice.  After the 40th year a  gradual but progressive decline in  the 
percentage of protective sera occurs. 
Quantitative Aspects of the Protective Tests.--Certain sera which were tested by 
the  present  method were  also  tested  by Andrewes,  Laidlaw,  and  Smith  (5). 
These sera were the ones mentioned above, which were obtained from Alaskan 
convalescents,  and in addition there were 6 specimens of dried serum from Phila- 
delphia. 4  The British workers  attempt to measure the antibody content of a 
serum more accurately by testing the protective action of progressive dilutions of 
the serum against a filtrate of virus suspension.  The results with the unknown 
serum are then interpreted by direct comparison with corresponding dilutions of a 
standard hyperimmune horse serum.  The serum is given a rating on this basis. 
Thus, S indicates that the test serum is as potent as the standard; S/5 or S/25 
indicates that the unknown serum is 1/5 or 1/25 as strong as the standard. 
A comparison of the results obtained when the same sera were tested 
by the method used in the present study and by the  method of the 
3 The Alaskan  sera were obtained by Drs. H. Pettit and D. S. Pepper, of the 
University of Pennsylvania, immediately following the epidemic, and were kindly 
made available to us by Dr. Mud& 
The serum of the Puerto Rican subjects was obtained by Dr. W. C. Earle, of 
the International Health Division of the Rockefeller  Foundation, to whom  we 
should like to express our appreciation. 
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TABLE IV 
Comparison  of Results Obtained  with Dried  Serum 
Sample  No. 
C-91 
C-74 
C-109 
C-111 
C-82 
C-121 
Severity of pulmonary lesions in Mouse No. 
++++ 
++ 
0 
0 
0 
+++ 
++++* 
+ 
0 
0 
0 
+++ 
++++* 
+ 
+ 
0 
0 
++++ 
+ 
+ 
4- 
0 
0 
++++ 
Result 
NP 
PP 
IP 
CP 
CP 
NP 
A~drcwe$  ) 
results(5) 
S/25 
s/2s 
s/2s 
s 
s 
s/2s 
NP  =  no protection. 
PP  =  partial protection. 
IP  =  incomplete protection. 
CP  =  complete protection. 
0  ffi  no gross pulmonary lesions. 
4- to  +  +  +  +  =  progressive degrees of pulmonary involvement. 
S  =  test serum equal in potency to standard serum. 
S/5  ffi  ' ...............  diluted  1/5. 
S/25  ............. '  ....  1/25 
*  =  mouse died. 
TABLE  V 
Comparison  of Results  Obtained  in  Tests Made  with Alaskan  Sera 
Seruln 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
10 
11 
13 
14 
15 
16 
17 
Influenza convalescent 
22 yrs., 6 wits. ago 
60  "  severe, 3 wks. ago 
40  "  mild,  2  .... 
16  "  "  1 wk. ago 
70  "  severe, 2 wks. ago 
63  "  "  2  "  " 
70  "  "  2  "  " 
44  "  "  1 wk. ago 
17  "  mild,  2 wks. ago 
21  "  severe, 2  "  " 
42  "  nard,  2  "  " 
18  "  "  2  "  " 
19  "  "  2  "  " 
25  "  severe, 3  "  " 
19  "  mild,  1 wk. ago 
Severity of pulmonary 
lesions in  Mouse  No, 
1  2  3  4 
0  0  0  -I- 
0  0  .4- 
0  0  0 
0  0  0 
0  0  0 
+  +  ++ 
o  o  o 
+  o  o 
o  o  o 
o  o  o 
o  -4-  o 
o  o  o 
o  o  4- 
+  +  ++ 
o  o  o 
Result 
CP 
0  CP 
0  CP 
0  CP 
0  CP 
q-q-  PP 
0  CP 
0  CP 
0  CP 
0  CP 
0  CP 
0  CP 
0  CP 
+  PP 
0  CP 
Andrewes'  classification 
(5) 
s--s/s 
s 
S/25 
S 
s--s/s 
SlS--s/25 
s 
Less than S/25 
S 
S/5 
s/s--s/2s 
s/s 
s/5 
Less than S/25 
s--s/s THOMAS  ~RANCIS,  JR.,  AND  T.  P.  MAGILL  563 
English workers shows that the correlation is quite good (Tables IV 
and V).  All the sera which the latter workers have assayed S or S/5 
have been found by our method to be completely protective.  Among 
the sera which are graded as S/25 by the titration method, the agree- 
ment is not so consistent; certain of them have, in our hands, been 
completely protective  while others protect partially  or  very little. 
Nevertheless, the results indicate that both methods afforded informa- 
tion  indicative of  the  antibody  content of  the  sera studied.  The 
severity of lung lesions in the mouse which result from the intranasal 
inoculation of a serum-virus mixture is inversely proportional to the 
antibody content of the serum. 
DISCUSSION 
The present  report presents  the results of tests  designed for the 
demonstration  of  protective  antibodies  against  a  strain  of  human 
influenza virus in the serum of 136 individuals of all ages.  In addition 
to the fact that statistically their numbers are small, interpretation of 
the results is limited by several factors: (a) that the sera were collected 
in  three large  cities along  the Atlantic seaboard;  (b)  that  the  age 
distribution of the individuals from whom the sera were collected was 
not :the same in all three cities;  (c)  that the history of influenza is 
unreliable; and  (d)  that  the previous data  regarding persistence of 
immunity following influenza are  very inconclusive.  Nevertheless, 
the similarity to the results recently reported by Andrewes, Laidlaw, 
and Smith  (5)  with sera of human individuals of different ages in 
England  suggests  that  the  results  are  significant.  Although  their 
tests were made with a  different strain  (W. S.)  of human influenza 
virus, the percentages of completely protective sera at different age 
periods found in the present study do not differ greatly from theirs. 
For purposes of discussion it may be assumed that, apart from new- 
born infants, the presence of specific protective antibodies in the serum 
of an individual is the result of past infection with the virus of human 
influenza.  Evidence for the validity of this assumption has previously 
been  presented,  which shows  that  recovery from influenza in  the 
human individual has been accompanied by the development of circu- 
lating antiviral bodies, whereas, in the course of the ordinary common 
cold or of pneumococcus pneumonia, the development of antibodies 664  ANTIBODIES  FOR  HUMAN  INFLUENZA  VIRUS 
against the human influenza virus has not been observed (3).  More- 
over, the distribution of the virus infection is widespread, as evidenced 
by the fact that in the past 2 years strains of virus have been recovered 
from epidemics of human influenza in England (1, 7), Puerto Rico, the 
United States (2), and Alaska (7).  In view of these facts it is reason- 
able to utilize the results of the protection tests in an attempt to inter- 
pret the epidemiology of human influenza. 
Considering only those sera which contained sufficient antibody to 
protect mice completely against human influenza virus, it was found 
that, excluding the 1st year of life, influenza attacks individuals of all 
ages.  59 per cent of those between 1 and 20 years of age, 52.5 per cent 
of those between 20 and 40 years, and 42.5 per cent of those over 40 
years of age possessed  a  high  titer  of protective antibodies.  The 
occurrence of antibodies at all ages agrees with the customary experi- 
ence that in outbreaks of influenza individuals of all ages are attacked. 
The high incidence of antibodies in children and young adults consti- 
tutes further evidence that the human influenza virus is prevalent at 
the present time. 
The interpretation of the results of protection tests with sera which 
afford partial protection to mice is at the present time impaired by lack 
of knowledge.  Except when based upon history--and this is unre- 
liable--observations regarding the persistence of anti-influenzal anti- 
bodies for more than 1 year have not been made.  Furthermore, the 
presence of protective antibodies in the blood of adults does not indi- 
cate whether they were acquired as the result of a recent infection or 
whether they have persisted for years following an attack of influenza. 
That the partially protective action of a serum does not belong in the 
category of natural antibodies is shown by the fact that this capacity 
is not destroyed by heating the serum at 60°C.  However, 2 cases of 
influenza have been observed in which the serum of the individual 
taken at the height of the disease  exerted partial protection against 
the virus,  but after recovery the  serum completely neutralized the 
virus.  These observations suggest that other individuals whose sera 
do not protect completely against the virus of human influenza may 
be susceptible to infection with the virus.  Moreover, of 31  sera ob- 
tained from individuals who had suffered from influenza in 1934-35, 27, 
or 87 per cent, possessed  sufficient  antibody to neutralize the virus 
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It seems quite probable, therefore, that the individuals from whom 
the partially protective sera were obtained are those who have suffered 
from influenza  in  the  past,  but  whose  circulating  antibodies  have 
decreased with the passage of time.  This interpretation is supported 
by an observation of Andrewes, Laidlaw, and Smith (5), in which they 
noted a marked decline in the antibody titer of the serum of an indi- 
vidual within 2 years following the attack. 
If the partially protective sera are included with the fully protective 
sera, the trend of the findings is modified,  Under these conditions all 
newborn  infants  are found to possess  antibodies, most  probably of 
maternal origin.  These are lost to a  great extent in the 1st year of 
life, and are superseded by antibodies presumably developed in  re- 
sponse to infection.  Between the 1st and 5th years the serum either 
protects completely or not at all, suggesting recent infection.  There- 
after, the incidence mounts to  the 20 to 40  age period, when 90 per 
cent of the sera contain measurable amounts of protective antibodies. 
This peak may be attributed to the increased percentage of partially 
protective sera during these years.  Beyond the 40th year the per- 
centage of negative sera increases.  Whether the decline in  the per- 
centage of positive results among older persons indicates that these 
individuals have wholly escaped infection, or whether it indicates a 
further step in the loss of antibodies previously acquired, is problem- 
atic.  If, however, as the statistics of the 1918 epidemic indicate (8), 
the case rate was highest in children and young adults, the high inci- 
dence of antibodies in the present age groups between 20 and 40 years 
of age might be considered to be a  result of infection experienced in 
1918.  The decreased percentage of protective sera in  the older age 
groups corresponds with the decreased incidence of infection in adults 
in  1918.  Regardless of the relation of the present study to the epi- 
demic of 1918-19, the results suggest that the human influenza virus 
is related etiologically to the disease which has prevailed in the isolated 
epidemics of recent years. 
Shope (9) tested 124 of the sera used in the present study against the 
virus of swine influenza.  Certain distinct differences appear in  the 
distribution  of  antibodies  against  swine influenza virus  when  com- 
pared with those against human influenza virus.  The chief differences 
observed are, that against swine influenza virus little or no protective 666  ANTIBODIES FOR I/UMAN IN~LUEBIZA VIllUS 
action is observed with sera of children under 10 years of age, whereas 
practically all adult sera protect completely against the swine virus. 
The period of highest incidence of protective antibodies against swine 
influenza virus is the same (from 20 to 40 years) as that in which the 
combined  percentage  of  complete  and  partial  protection  against 
human influenza virus is greatest. 
The serum of 40 of 79 individuals over the age of 12 years exerted 
complete protection against both human and swine strains of influenza 
virus.  On the other hand, certain sera protected completely against 
human (P. R. 8) virus, but not against the swine virus, and rice versa.  It 
is seen, therefore, that in addition to the differences in the protective 
action noted in the serum of children when tested against the human 
and swine influenza viruses,  specific differences are  to  be  observed 
in the protective action of the serum of adult individuals tested against 
the human and swine viruses. 
Studies (10) with the sera of animals convalescent from experimental 
infection with  human  or  swine  influenza virus,  or  animals  hyper- 
immunized by  repeated inoculations of virus, have shown that  the 
immune response to  the primary infection is  specific  for the  virus 
employed.  After  repeated  reinfections,  however,  the  serum  may 
develop a  broader zone of activity, and may confer some degree of 
passive  immunity to  mice  against  the  heterologous virus  as well. 
This effect is most noticeable in animals repeatedly infected with the 
human influenza virus, and it suggests that the swine influenza virus 
possesses antigenic components which are also present in the human 
influenza  virus  as  secondary  antigens.  It  seems  possible  that  a 
similar set of conditions may obtain in the human population.  The 
serum of children 1 to 5 years old exerts a specific effect against the 
human influenza virus, owing presumably to  a  single attack.  The 
serum of older children and adults who may have had repeated expo- 
sures to the human influenza virus might, on the other hand, have 
developed the broader immune zone which would then afford a certain 
degree of cross-protection against the virus of swine influenza.  Con- 
versely, if human individuals had been attacked by the virus of swine 
influenza, partial protection might be exhibited by the serum against 
human influenza virus. 
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poliomyelitis virus deserve to be considered in  this general relation. 
It was found that in neutralization tests performed with the serum of 
normal children or of children convalescent from poliomyelitis against 
the older passage strain of poliomyelitis, no difference could be detected 
between the effects of normal and convalescent serum.  The results 
appeared to  bear a  closer relationship to age than to  actual illness. 
When the same sera were tested against a more recently isolated strain, 
it was found that convalescent children's serum protected against this 
strain,  while normal serum did not.  The  age differences in  serum 
protection  against  the  older  strain  of poliomyelitis virus  are  very 
similar to those noted by Shope (9) with the serum of human individ- 
uals  tested  against  swine  influenza  virus.  The  high  incidence  of 
protective  antibodies  in  the  serum  of  recent  poliomyelitis  conva- 
lescents against the recently recovered strain of poliomyelitis is also 
similar to that obtained with the serum of recent influenza convales- 
cents against the human influenza virus. 
No attempt at a  final interpretation of the epidemiological signifi- 
cance of the  results  of the present study can be  made.  Sufficient 
evidence regarding the persistence of immunity to  human influenza 
has not yet been accumulated to justify detailed inferences concerning 
the prevalence of influenza in the past.  The proportion of positive 
sera in  young children certainly indicates a  prevalence of infection 
due to the human influenza virus at the present time.  This indica- 
tion  is  strengthened by the recovery of strains  of the virus during 
recent epidemics of human influenza, as well as by the fact that the 
serum  of  recently recovered individuals,  in  the  great  majority  of 
instances, possesses a high titer of antibodies against strains of human 
influenza virus. 
SUMMARY 
The results of mouse protection tests with 136 human sera and a 
strain of human influenza virus are described.  After the 1st year of 
life, the sera of approximately half the individuals tested contained 
sufficient antibody to furnish complete protection to mice.  A much 
higher percentage of the sera obtained from individuals recently con- 
valescent from influenza exerted a  completely protective effect.  On 
the other hand, certain sera protected only partially under the condi- 
tions of the tests. 668  ANTIBODIES FOR HUMAN INFLUENZA VIRUS 
The results have been compared with those obtained by Shope in 
tests  done with  the  same sera  against swine influenza virus.  The 
possible epidemiological significance of the results is discussed. 
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